Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration

Cancer Cytopathology

Volumn 120, Issue 5, 2012, Pages 342-350

  Monaco, Sara E ^a   Pantanowitz, Liron ^a   Khalbuss, Walid E ^a   Benkovich, Vanessa A ^a   Ozolek, John ^a   Nikiforova, Marina N ^a   Simons, Jeffrey P ^a   Nikiforov, Yuri E ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Children; Cytopathology; Fine needle aspiration; Molecular; Pediatric; Thyroid

Indexed keywords

B RAF KINASE;

ADOLESCENT; ADULT; ARTICLE; BRAF GENE; CELL STRUCTURE; CHILD; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLICULAR CARCINOMA; FOLLOW UP; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; ONCOGENE RET; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THYROID CANCER; THYROID FINE NEEDLE ASPIRATION; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; BIOPSY, FINE-NEEDLE; CARCINOMA; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84871732424     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21199     Document Type: Article

References (33)

1. Yeung MJ, Serpell JW. Management of the solitary thyroid nodule. Oncologist. 2008;13:105-112.
2. Niedzela M. Pathogenesis, diagnosis, and management of thyroid nodules in children. Endocr Relat Cancer. 2006;13:427-453.
3. Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, Stevens W. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med. 1991;91:363-370.
4. Altincik A, Demir K, Abaci A, Bober E, Buyukgebiz A. Fine-needle aspiration biopsy in the diagnosis and follow-up of thyroid nodules in childhood. J Clin Res Pediatr Endocrinol. 2010;2:78-80.
5. Canadian Pediatric Thyroid Nodule Study Group. The Canadian Pediatric Thyroid Nodule Study: an evaluation of current management practices. J Pediatr Surg. 2008;43:826-830.
6. Hoperia V, Larin A, Jensen K, Bauer A, Vasko V. Thyroid fine needle aspiration biopsies in children: study of cytological-histological correlation and immunostaining with thyroid peroxidase monoclonal antibodies. Int J Pediatr Endocrinol. 2010;2010:690108.
7. Raab SS, Silverman JF, Elsheikh TM, Thomas PA, Wakely PE. Pediatric thyroid nodules: disease demographics and clinical management as determined by fine needle aspiration biopsy. Pediatrics. 1995;95:46-49.
8. Cooper DS, Doherty GM, Haugen BR, et al American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109-142.
9. Kim DL, Song KH, Kim SK. High prevalence of carcinoma in ultrasonography-guided fine needle aspiration cytology of thyroid nodules. Endocr J. 2008;55:135-142.
10. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color- Doppler features. J Clin Endocrinol Metab. 2002;87:1941-1946.
11. Roy R, Kouniavsky G, Schneider E, et al. Predictive factors of malignancy in pediatric thyroid nodules. Surgery. 2011;150:1228-1233.
12. Arda IS, Yildirim S, Demirhan B, Firat S. Fine needle aspiration biopsy of thyroid nodules. Arch Dis Child. 2001;85:313.
13. Bargren AE, Meyer-Rochow GY, Sywak MS, Delbridge LW, Chen H, Sidhu SB. Diagnostic utility of fine-needle aspiration cytology in pediatric differentiated thyroid cancer. World J Surg. 2010;34:1254-1260.
14. Corrias A, Einaudi S, Chiorboli E, et al. Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches. J Clin Endocrinol Metab. 2001;86:4644.
15. Izquierdo R, Shankar R, Kort K, Khurana K. Ultrasound-guided fine-needle aspiration in the management of thyroid nodules in children and adolescents. Thyroid. 2009;19:703.
16. Khozeimeh N, Gingalewski C. Thyroid nodules in children: a single institution's experience. J Oncol. 2011;2011:974125.
17. Stevens C, Lee JKP, Sadatsafavi M, Blair GK. Pediatric thyroid fine-needle aspiration cytology: a meta-analysis. J Pediatr Surg. 2009;44:2184-2191.
18. Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for the cytological diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36:425-437.
19. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology: definitions, criteria, and explanatory notes. New York, NY: Springer; 2010.
20. Nikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94:2092-2098.
21. Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96:3390-3397.
22. Scholz S, Smith JR, Chaignaud, Shamberger RC, Huang SA. Thyroid surgery at Children's Hospital Boston: a 35-year single-institution experience. J Pediatr Surg. 2011;46:437-442.
23. Bongarzone I, Fugazzola L, Vigneri P, et al. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin EndocrinolMetab. 1996;81:2006-2009.
24. Soares P, Fonseca E, Wynford-Thomas D, Sobrinho-Simoes M. Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? J Pathol. 1998; 185:71-78.
25. Tallini G, Santoro M, Helie M, et al. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res. 1998;4:287-294.
26. Bounacer A, Wicker R, Caillou B, et al. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene. 1997;15: 1263-1273.
27. Klugbauer S, Lengfelder E, Demidchik EP, et al. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene. 1995;11: 2459-2467.
28. Kumagai A, Namba H, Saenko VA, et al. Low frequency of BRAF1796A mutations in childhood thyroid carcinomas. J Clin Endocrinol Metab. 2004;89:4280-4284.
29. Elisei R, Ugolini C, Viola D, et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab. 2008;93: 3943-3949.
30. Xing M, Clark D, Guan H, et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol. 2009;27:2977-2982.
31. Singh RS, Wang HH. Eliminating the "atypia of undetermined significance/follicular lesion of undetermined significance" category from the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2011;136:896-902.
32. Grigsby PW, Gal-or A, Michalski JM, et al. Childhood and adolescent thyroid carcinoma. Cancer. 2002;95:724-729.
33. Ries L, Melbert D, Krapcho M, et al. SEER cancer statistics review. Bethesda, MD: National Cancer Institute; 2008.